Edition:
United States

Alkermes Plc (ALKS.OQ)

ALKS.OQ on NASDAQ Stock Exchange Global Select Market

57.79USD
25 May 2017
Change (% chg)

$-0.46 (-0.79%)
Prev Close
$58.25
Open
$58.68
Day's High
$58.68
Day's Low
$57.76
Volume
24,756
Avg. Vol
327,478
52-wk High
$62.50
52-wk Low
$39.65

ALKS.OQ

Chart for ALKS.OQ

About

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central... (more)

Overall

Beta: 2.24
Market Cap(Mil.): $8,923.35
Shares Outstanding(Mil.): 153.19
Dividend: --
Yield (%): --

Financials

  ALKS.OQ Industry Sector
P/E (TTM): -- 138.86 17.42
EPS (TTM): -1.32 -- --
ROI: -12.94 2.17 -5.45
ROE: -16.11 0.04 -4.73

BRIEF-Alkermes CEO Richard Pops' 2016 total compensation was $9.6 mln vs $12.4 mln in 2015

* CEO Richard Pops' 2016 total compensation was $9.6 million versus $12.4 million in 2015 - sec filing Source text (http://bit.ly/2p9SZ48) Further company coverage:

Apr 13 2017

BRIEF-Alkermes Q4 non-gaap earnings per share $0.15

* Alkermes plc reports financial results for the year ended dec. 31, 2016 and provides financial expectations for 2017

Feb 15 2017

More From Around the Web

Competitors

Earnings vs. Estimates